KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Other Non-Current Assets: 2019-2021

Historic Other Non-Current Assets for Esperion Therapeutics (ESPR) over the last 2 years, with Dec 2021 value amounting to $50.0 million.

  • Esperion Therapeutics' Other Non-Current Assets changed negligibly% to $50.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $50.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $50.0 million for FY2021, which is N/A change from last year.
  • Per Esperion Therapeutics' latest filing, its Other Non-Current Assets stood at $50.0 million for FY2021, which was up 5,287.93% from $928,000 recorded in FY2019.
  • In the past 5 years, Esperion Therapeutics' Other Non-Current Assets ranged from a high of $50.0 million in FY2021 and a low of $928,000 during FY2019.
  • Moreover, its 2-year median value for Other Non-Current Assets was $25.5 million (2019), whereas its average is $25.5 million.